Gene therapy for cystic fibrosis G offers a promising approach to treat the root cause of the disease. By delivering functional copies of the CFTR gene into the cells of patients, gene therapy for cystic fibrosis aims to correct the defective chloride channels responsible for the symptoms. This innovative treatment has the potential to improve lung function and quality of life. Ongoing research in gene therapy for cystic fibrosis continues to refine delivery methods for better therapeutic outcomes.